Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Revenue

Rohto Pharmaceutical had revenue of 81.96B JPY in the quarter ending June 30, 2025, with 19.91% growth. This brings the company's revenue in the last twelve months to 322.23B, up 15.90% year-over-year. In the fiscal year ending March 31, 2025, Rohto Pharmaceutical had annual revenue of 308.63B with 13.95% growth.

• Revenue (ttm): 322.23B
• Revenue Growth: +15.90%
• P/S Ratio: 1.72
• Revenue / Employee: 35.24M
• Employees: 9,144
• Market Cap: 555.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%